InflaRx (NASDAQ:IFRX – Get Rating) had its target price trimmed by HC Wainwright from $10.00 to $9.00 in a report released on Friday, The Fly reports. The firm currently has a buy rating on the stock. Other equities analysts have also issued research reports about the company. Lifesci Capital raised InflaRx from a market perform […]
Lifesci Capital upgraded shares of InflaRx (NASDAQ:IFRX – Get Rating) from a market perform rating to an outperform rating in a research report released on Wednesday, Benzinga reports. Separately, HC Wainwright reissued a buy rating and set a $6.00 price target on shares of InflaRx in a research report on Thursday, March 23rd. Four analysts […]
Lifesci Capital upgraded shares of InflaRx (NASDAQ:IFRX – Get Rating) from a market perform rating to an outperform rating in a research report sent to investors on Wednesday, Benzinga reports. Separately, HC Wainwright reissued a buy rating and set a $6.00 price target on shares of InflaRx in a research report on Thursday, March 23rd. […]
InflaRx (NASDAQ:IFRX – Get Rating) was upgraded by research analysts at Lifesci Capital from a “market perform” rating to an “outperform” rating in a research note issued to investors on Wednesday, Benzinga reports. Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 target price on shares of InflaRx in a research note on […]